SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
04-Apr-22 7:07 PM View: | Neogenomics Inc. (NEO) | 01-Apr-22 | Grant | 82,305 | -- | -- | 108% 76.38K to 158.68K | |
03-Mar-22 7:57 PM View: | Neogenomics Inc. (NEO) | 02-Mar-22 | Payment of Exercise | 867 | -- | -- | (1%) 77.25K to 76.38K | |
03-Mar-22 7:57 PM View: | Neogenomics Inc. (NEO) | 01-Mar-22 | Grant | 35,030 | -- | -- | 83% 42.22K to 77.25K | |
30-Dec-21 6:02 PM View: | Neogenomics Inc. (NEO) | 30-Dec-21 | Grant | 30,572 | -- | -- | 263% 11.64K to 42.22K | |
26-Nov-21 4:14 PM View: | Neogenomics Inc. (NEO) | 26-Nov-21 | Market Sale (Planned) | 33,334 | $36.85 | $1,228,360.00 | (74%) 44.98K to 11.64K | (2%) |
26-Nov-21 4:14 PM View: | Neogenomics Inc. (NEO) | 24-Nov-21 | Market Sale (Planned) | 33,333 | $36.84 | $1,227,990.00 | (43%) 78.31K to 44.98K | (2%) |
26-Nov-21 4:14 PM View: | Neogenomics Inc. (NEO) | 23-Nov-21 | Market Sale (Planned) | 33,333 | $37.19 | $1,239,650.00 | (30%) 111.64K to 78.31K | (1%) |
04-Mar-21 9:06 PM View: | Neogenomics Inc. (NEO) | 02-Mar-21 | Grant | 4,655 | -- | -- | 4% 106.99K to 111.64K |